financetom
Business
financetom
/
Business
/
Natgas utility firm NiSource misses Q3 adjusted EPS estimates, reaffirms 2025 guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Natgas utility firm NiSource misses Q3 adjusted EPS estimates, reaffirms 2025 guidance
Oct 29, 2025 3:59 AM

Overview

* NiSource Q3 2025 adjusted EPS misses analyst expectations

* Company reaffirms 2025 non-GAAP adjusted EPS guidance, introduces 2026 guidance

* Announces $28 bln capital expenditure plan, including $7 bln for data centers

Outlook

* NiSource ( NI ) reaffirms upper half of 2025 non-GAAP adjusted EPS guidance of $1.85-$1.89

* Company expects 2026 non-GAAP consolidated adjusted EPS between $2.02-$2.07

* NiSource ( NI ) projects 6%-8% annual EPS growth from 2026 to 2030

Result Drivers

* CAPITAL EXPENDITURE PLAN - NiSource ( NI ) announced a $28 bln capital expenditure plan, with $7 bln allocated to data centers, driving future growth

* WEATHER IMPACT - Weather variations negatively impacted operating income, affecting adjusted net income

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $0.19 $0.19

Adjusted (10

EPS Analysts

)

Q3 EPS $0.20

Q3 Net $94.70

Income mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the multiline utilities peer group is "buy"

* Wall Street's median 12-month price target for NiSource Inc ( NI ) is $46.00, about 5.7% above its October 28 closing price of $43.39

* The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 21 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan says lower US tariffs will take effect by September 16
Japan says lower US tariffs will take effect by September 16
Sep 8, 2025
TOKYO, Sept 9 (Reuters) - U.S. tariffs on Japanese goods including cars and auto parts are set to be lowered by September 16, Japan's tariff negotiator Ryosei Akazawa said on Tuesday. Citing a U.S. Federal Register document dated September 9 that formalised President Donald Trump's executive order on the U.S.-Japan trade deal, Akazawa said in a press conference the revised...
Dogecoin Treasury Move Sends Stock Of Company Chaired By Elon Musk's Lawyer 62% Higher After-Hours
Dogecoin Treasury Move Sends Stock Of Company Chaired By Elon Musk's Lawyer 62% Higher After-Hours
Sep 8, 2025
Shares of CleanCore Solutions Inc. ( ZONE ) exploded in Monday's after-hours trading after the company acquired $68 million in Dogecoin (CRYPTO: DOGE) to boost its newly launched treasury strategy. ZONE shares are climbing with conviction. See the trading setup here. CleanCore Bolsters DOGE Treasury The stock soared 62.96% after-hours, extending its returns from a healthy regular trading session. CleanCore, a...
Sam Altman-Founded Project's World Token Soars 47%: Here's Why Its Moving
Sam Altman-Founded Project's World Token Soars 47%: Here's Why Its Moving
Sep 8, 2025
World (CRYPTO: WLD) token defied gravity on Monday after a Nasdaq-listed firm embraced it as its primary treasury reserve asset. WLD Token Lifts Crypto Market WLD, the native currency of the Sam Altman-founded identity verification project, boomed nearly 48% in the last 24 hours, becoming the second-highest gainer among coins with a market value greater than $1 billion. The coin...
Novartis to acquire Tourmaline Bio in deal valuing it at $1.4 billion
Novartis to acquire Tourmaline Bio in deal valuing it at $1.4 billion
Sep 8, 2025
BERLIN, Sept 9 (Reuters) - Switzerland's Novartis will acquire Tourmaline Bio ( TRML ) with an offer price of $48 per share, in a deal valuing the New York-based company at $1.4 billion on a fully diluted basis, it said on Tuesday. Novartis said it expected the deal to close in the fourth quarter and for Tourmaline to become an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved